Volume 8, Issue 2, September 2014, Pages 482–488
Manjusha Pandey1, R.C. Pande2, Shailja Pant3, and K.P. Singh4
1 Microbiology Department, King George's Medical University, Lucknow, Uttar Pradesh, India
2 Ex. Professor and Head Department of Microbiology, Pathology and Blood Bank, Vivekananda Polyclinic and Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
3 Principal and Head Department of Microbiology, Dolphin Paramedical Institute, Dehradun Uttarankhand, India
4 Professor, Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India
Original language: English
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In imuuno-compromised patient with tuberculosis, drug-resistant tuberculosis (DR-TB) is an emerging problem that adversely affects treatment results and public health in the developing countries. Objective of this study was the emergence of Multi
Author Keywords: Acid-fast bacilli, mycobacterium, human immune-deficiency virus, antiretroviral therapy, tuberculosis.
Manjusha Pandey1, R.C. Pande2, Shailja Pant3, and K.P. Singh4
1 Microbiology Department, King George's Medical University, Lucknow, Uttar Pradesh, India
2 Ex. Professor and Head Department of Microbiology, Pathology and Blood Bank, Vivekananda Polyclinic and Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
3 Principal and Head Department of Microbiology, Dolphin Paramedical Institute, Dehradun Uttarankhand, India
4 Professor, Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India
Original language: English
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
In imuuno-compromised patient with tuberculosis, drug-resistant tuberculosis (DR-TB) is an emerging problem that adversely affects treatment results and public health in the developing countries. Objective of this study was the emergence of Multi
Author Keywords: Acid-fast bacilli, mycobacterium, human immune-deficiency virus, antiretroviral therapy, tuberculosis.
How to Cite this Article
Manjusha Pandey, R.C. Pande, Shailja Pant, and K.P. Singh, “The Emergence of Multi – drug resistant tuberculosis in HIV Patients,” International Journal of Innovation and Applied Studies, vol. 8, no. 2, pp. 482–488, September 2014.
